The Biotechnology Industry
The primary objective of the biotechnology industry is to create new biologically-active ingredients, for the treatment of disease, the pharmaceutical industry, and the management of farming.
The U.S. is actually the world leader in biotechnology, currently supplying employment for a lot more than 300,000 individuals in more than 6,000 U.S. biotech businesses, with an believed market capitalization of roughly United states dollar 281 billion in 2008. The biotechnology industry offers a lot more than tripled in size because 2000, along with income growing from USD 25 billion in 2000 to a lot more than United states dollar 80 billion in 08. In 2007, Amgen, Corporation., the world’s biggest biotechnology company, achieved total sales of United states dollar 14.7 billion. Expectations are that the biotechnology market will increase to more than United states dollar 130 billion through 2011.
Geographically, the U.S. company accounts for 65% of the biotechnology marketplace, Europe 23%, Canada 7%, Australia 3%, and the rest of the world, 2%.
Today, genomics and bioinformatics development both are becoming pursued within major pharmaceutical companies. There have been key collaborations along with traditional This technologies companies such as Sun microsystems, Hitachi, Ltd., Samsung, SK Telecomm and Motorola. The U.S. biotechnology research and pharmaceutical industry spent a report United states dollar 8.5 billion in 2007 on the R&D of new medicines and vaccines. As of 2006, the biotechnology industry compared positively with the pharmaceutical industry in terms of R&D expenditures per employee. Venture capital opportunities in bioscience companies reached United states dollar 11.6 billion in 2007.
Ernst & Young reported that in 2006, 82 publicly-traded Canadian biotech firms stated S3.2 billion in income, accounting for 4.4% of worldwide biotech income. Individual health accounts for the largest segment of the Canadian biotech industry, representing over fifty percent the curiosity of just about all biotech businesses, approximately 70% of all biotech income and nearly 90% of just about all biotech R&D. Bioinforrnatics provides an important capacity for the Canada biotech industry, covering genomics and other “omics”, tissue engineering and medication breakthrough technologies.
Canadian bioinformatics companies consist of Bioinformatics Solutions, Inc., Genetic make-up Attractions, Inc., and Kinexus Bioinformatics Corporation. Montreal, Quebec, canada ,, offers Canada’s leading biotech cluster, followed by Greater toronto area, Ontario; Vancouver, Bc; and Winnipeg, Manitoba.
Five Eu (E.U.) fellow member states-Denmark, Finland, Germany, Sweden and the U.K.-continue to be world frontrunners in biotech innovation along with the U.S. and Asia. In the second half’ of 2007, European biotech companies reached USD 765.3 million in venture capital investment. In The month of january and February of 2008, venture capital funds spent a complete of United states dollar 145.6 million into new Western biotech companies; however, along with the financial challenges of the second option part of the year, many European biotech firms may find it harder to raise cash in early ’09.
The Biotechnology Industry Business of Indonesia (BlO Deutschland), situated in Berlin, has more than 180 people, including businesses, BioRegions, and sector providers. The goal of the business is actually to assistance and promote a steady economy through development in bioscience. Among the German biotech companies tend to be the Biotechnology Research and Info System (BRAIN AG), 4SC. AG, Bionas, UmbEl and Direvo, that recently (Sept 2008) was purchased by the German pharmaceutical and chemical substances giant Bayer Health care. In view of’ the growing German biotech sector, conventional German scientific the likes of Eppendorf, AG, Sartorius, AG and Qiagen also have become into the act.